U.S., Feb. 11 -- An application to own the trademark for 'INTRAVASA' has been filed on Jan. 23, 2025.
Owner(s):
Theaprin Pharmaceuticals, Inc.; 150 Motor Pkwy, Ste 401, , NEW YORK
Goods and/or Services:
For: Antipyretic, analgesic, and anti-inflammatory preparations; Veterinary preparations, namely, antipyretics, analgesics, anti-inflammatories preparations and antioxidants; Pharmaceutical preparations for the treatment of COVID-19 cytokine storm as adjunctive therapy, acute myocardial infarction, acute thrombotic stroke, Mild to Moderate pain and Moderate to Severe Pain
Class(es): 005, 006, 018, 044, 046, 051, 052
For: Antioxidants for medical purposes, namely, antioxidants for use in the manufacture of pharmaceuticals, antioxidants ...